Skip to content

Effect of Iron Supplementation for Treatment of Anemia in Pregnancy on Maternal and Newborn Outcomes in Belgaum District, Karnataka

Evaluation of effect of Iron Sucrose Vs Ferrous Ascorbate for treatment of Anemia in pregnancy on maternal and newborn outcomes at selected Primary Health Centers of Belgaum District - A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/12/003199
Enrollment
240
Registered
2012-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium Health Condition 2: null- Pregnant women between 12 to 16 weeks of gestation with Hemoglobin less than 11 gms %

Interventions

Intervention1: IV Iron Sucrose 5 ml ampoule - Inj. Orofer S: Single dose of Iron Sucrose, diluted in 100 ml normal saline, will be administered by intravenous infusion. The dose for total iron sucro

Sponsors

KLE University Belgaum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pregnant women in second trimester of pregnancy 2)Hemoglobin less than 11 gms%

Exclusion criteria

Exclusion criteria: 1)Hemoglobin less than 7 gms% 2)Systemic disorders. 3)Women who have received blood transfusion during the present pregnancy and who are likely to receive blood transfusion. 4)Anemiaâ??s due to causes other than iron deficiency. 5)Allergy to iron

Design outcomes

Primary

MeasureTime frame
HemoglobinTimepoint: 16weeks, 20 weeks and 24 weeks of pregnancy

Secondary

MeasureTime frame
Newborn outcomes to be assessed will be birth weight, and survival at 28 days. Obstetric outcome like preterm labor, infections, recorded adverse effects and clinical end points like maternal mortality and morbidity. Pregnancy outcomes like type of birth, gestational age at birth, birth weight, and blood transfusion history and hospitalization.Timepoint: At delivery and postpartum day 42.

Countries

India

Contacts

Public ContactShivaprasad S Goudar

KLE Universitys Jawaharlal Nehru Medical College

brajten@gmail.com8312444089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026